|
DE1470356A1
(de)
|
1964-01-15 |
1970-04-30 |
Thomae Gmbh Dr K |
Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
|
|
JP3126541B2
(ja)
|
1993-03-26 |
2001-01-22 |
千寿製薬株式会社 |
ベンゾチアゾール誘導体、その製法及びその用途
|
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
NZ335823A
(en)
|
1997-04-22 |
2001-06-29 |
Neurocrine Biosciences Inc |
Thiophenopyridines, preparation as CRF receptor antagonists
|
|
EP1028964A1
(en)
|
1997-11-11 |
2000-08-23 |
Pfizer Products Inc. |
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
|
|
CL2003002287A1
(es)
|
2002-11-25 |
2005-01-14 |
Wyeth Corp |
COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
|
|
WO2004065392A1
(en)
|
2003-01-24 |
2004-08-05 |
Smithkline Beecham Corporation |
Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
|
|
WO2005007083A2
(en)
|
2003-06-18 |
2005-01-27 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
CA2540681C
(en)
|
2003-10-03 |
2014-08-12 |
The General Hospital Corporation |
Methods for altering mrna splicing and treating familial dysautonomia and other mechanistically related disorders
|
|
JP2009007341A
(ja)
|
2007-06-01 |
2009-01-15 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
|
EP2014663A1
(de)
|
2007-07-12 |
2009-01-14 |
Bayer Schering Pharma AG |
Thienopyrimidylamine als Modulatoren des EP2-Rezeptors
|
|
WO2009085226A2
(en)
|
2007-12-21 |
2009-07-09 |
Sirtris Pharmaceuticals, Inc. |
Inhibitors of cdc2-like kinases (clks) and methods of use thereof
|
|
BRPI0912245A2
(pt)
|
2008-03-05 |
2019-09-24 |
Takeda Pharmaceuticals Co |
composto, prodroga, medicamento, métodos de suprimir produção de açúcar em um mamífero e para a profilaxia ou o tratamento de diabetes em um mamífero, e, uso do composto
|
|
WO2010118367A2
(en)
|
2009-04-10 |
2010-10-14 |
Progenics Pharmaceuticals, Inc. |
Antiviral pyrimidines
|
|
WO2012012656A2
(en)
|
2010-07-21 |
2012-01-26 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
EP2611812A1
(en)
|
2010-09-01 |
2013-07-10 |
Ambit Biosciences Corporation |
Thienopyridine and thienopyrimidine compounds and methods of use thereof
|
|
DE102011111400A1
(de)
|
2011-08-23 |
2013-02-28 |
Merck Patent Gmbh |
Bicyclische heteroaromatische Verbindungen
|
|
EP2867236B1
(en)
|
2012-06-29 |
2017-06-14 |
Pfizer Inc |
Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors
|
|
WO2014124458A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases
|
|
CN105339371A
(zh)
|
2013-03-07 |
2016-02-17 |
葛兰素史密斯克莱有限责任公司 |
作为沉默调节蛋白调节剂的噻吩并[3,2-d]嘧啶-6-甲酰胺和类似物
|
|
CN110218727A
(zh)
|
2013-03-14 |
2019-09-10 |
萨勒普塔医疗公司 |
用于治疗肌营养不良的外显子跳跃组合物
|
|
CN103242341B
(zh)
|
2013-04-19 |
2015-12-09 |
中国科学院广州生物医药与健康研究院 |
噻吩并2，4取代嘧啶类化合物及其药物组合物与应用
|
|
US9879014B2
(en)
*
|
2013-07-12 |
2018-01-30 |
Kyoto University |
Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease
|
|
RU2692634C2
(ru)
|
2013-10-07 |
2019-06-25 |
Академиш Зикенхойс Лейден Х.О.Д.Н. Люмк |
Направляемое антисмысловым олигонуклеотидом удаление сайтов протеолитического расщепления, мутации hchwa-d и увеличенного числа тринуклеотидных повторов
|
|
KR102390370B1
(ko)
|
2014-02-12 |
2022-04-26 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
MA39987A
(fr)
|
2014-04-30 |
2017-03-08 |
Incyte Corp |
Procédés de préparation d'un inhibiteur de jak1 et nouvelles formes associées
|
|
CA2973949C
(en)
|
2015-01-16 |
2023-07-11 |
The General Hospital Corporation |
Compounds for improving mrna splicing
|
|
ES2865330T3
(es)
|
2015-04-29 |
2021-10-15 |
Janssen Pharmaceutica Nv |
Azabenzimidazoles y su uso como moduladores del receptor AMPA
|
|
KR102222186B1
(ko)
|
2015-08-13 |
2021-03-03 |
머크 샤프 앤드 돔 코포레이션 |
Sting 효능제로서 시클릭 디-뉴클레오티드 화합물
|
|
EP4285912A3
(en)
|
2015-09-25 |
2024-07-10 |
Ionis Pharmaceuticals, Inc. |
Compositions and methods for modulating ataxin 3 expression
|
|
IL294124B2
(en)
|
2015-12-10 |
2024-02-01 |
Ptc Therapeutics Inc |
Methods for treating huntington's disease
|
|
US10034861B2
(en)
|
2016-07-04 |
2018-07-31 |
H. Lundbeck A/S |
1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
|
|
EP3494229B1
(en)
|
2016-08-03 |
2023-10-25 |
Meiragtx UK II Limited |
High throughput cell-based screening for aptamers
|
|
EP3528816A4
(en)
|
2016-10-21 |
2020-04-08 |
Nimbus Lakshmi, Inc. |
TYK2 INHIBITORS AND USES THEREOF
|
|
GB201700814D0
(en)
|
2017-01-17 |
2017-03-01 |
Liverpool School Tropical Medicine |
Compounds
|
|
WO2018151326A1
(ja)
|
2017-02-20 |
2018-08-23 |
国立大学法人京都大学 |
スプライシング異常に起因する遺伝性疾病のための医薬組成物及び治療方法
|
|
US10538571B2
(en)
|
2017-11-27 |
2020-01-21 |
Coda Biotherapeutics, Inc. |
Compositions and methods for neurological diseases
|
|
WO2020123395A1
(en)
|
2018-12-10 |
2020-06-18 |
Ideaya Biosciences, Inc. |
2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors
|
|
CN109819066A
(zh)
|
2019-01-31 |
2019-05-28 |
平安科技（深圳）有限公司 |
一种基于地理位置的智能解析域名方法及装置
|
|
SG11202108519TA
(en)
|
2019-02-13 |
2021-09-29 |
Ptc Therapeutics Inc |
Thioeno[3,2-b] pyridin-7-amine compounds for treating familial dysautonomia
|
|
WO2020167624A1
(en)
|
2019-02-13 |
2020-08-20 |
Ptc Therapeutics, Inc. |
Pyrrolo[2,3-d]pyrimidine compounds for treating familial dysautonomia
|
|
MA54953A
(fr)
|
2019-02-13 |
2021-12-22 |
Denali Therapeutics Inc |
Composés, compositions et procédés
|
|
EP3929185A4
(en)
|
2019-02-19 |
2023-02-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
NITROGEN CONDENSED CYCLIC COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
|
CN113950529A
(zh)
|
2019-06-06 |
2022-01-18 |
豪夫迈·罗氏有限公司 |
靶向atxn3的反义寡核苷酸
|
|
US11798161B2
(en)
|
2019-11-26 |
2023-10-24 |
Koh Young Technology Inc. |
Method and apparatus for determining mid-sagittal plane in magnetic resonance images
|
|
CN115209955A
(zh)
|
2019-12-12 |
2022-10-18 |
Ptc医疗公司 |
治疗家族性自主神经功能障碍的化合物
|
|
US20230117831A1
(en)
|
2020-01-08 |
2023-04-20 |
The Broad Institute, Inc. |
Multi-functional chimeric molecules
|
|
US20240051968A1
(en)
|
2021-02-05 |
2024-02-15 |
Ptc Therapeutics, Inc. |
Methods for treating spinocerebellar ataxia type 3
|
|
EP4288059A4
(en)
|
2021-02-05 |
2025-01-08 |
PTC Therapeutics, Inc. |
Compounds for treating spinocerebellar ataxia type 3
|
|
EP4288441A4
(en)
|
2021-02-05 |
2024-12-11 |
PTC Therapeutics, Inc. |
Methods for treating spinocerebellar ataxia type 3
|
|
JP2024513566A
(ja)
|
2021-04-09 |
2024-03-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
標的基質の選択的修飾のための二官能性分子
|
|
EP4398987A4
(en)
|
2021-09-07 |
2025-07-09 |
Ptc Therapeutics Inc |
METHODS OF TREATMENT OF NEURODEGENERATIVE DISEASES
|
|
CN118251225A
(zh)
|
2021-09-07 |
2024-06-25 |
Ptc医疗公司 |
治疗神经退行性疾病的方法
|
|
MX2024002887A
(es)
|
2021-09-07 |
2024-05-28 |
Ptc Therapeutics Inc |
Metodos para tratar enfermedades neurodegenerativas.
|
|
US20250127789A1
(en)
|
2021-11-04 |
2025-04-24 |
Skyhawk Therapeutics, Inc. |
Compositions useful for modulating splicing
|
|
MA71255A
(fr)
|
2022-06-22 |
2025-04-30 |
Ptc Therapeutics, Inc. |
Composés pour le traitement de l'ataxie spinocérébelleuse de type 3
|